<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37497655</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Host genetic polymorphisms involved in long-term symptoms of COVID-19.</ArticleTitle><Pagination><StartPage>2239952</StartPage><MedlinePgn>2239952</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2239952</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2023.2239952</ELocationID><Abstract><AbstractText>Host genetic polymorphisms are recognized as a critical determinant of diversity in clinical symptoms of Coronavirus disease 2019 (COVID-19). Accordingly, this study aimed to determine possible associations between single nucleotide polymorphisms (SNPs) in 37 candidate genetic variants and clinical consequences of COVID-19 - especially long-term symptoms, Long COVID. A total of 260 COVID-19 patients, divided into mild (<i>n&#x2009;</i>=&#x2009;239) and severe (<i>n&#x2009;</i>=&#x2009;21) and further categorized based on the presence of Long COVID (no, <i>n&#x2009;</i>=&#x2009;211; yes, <i>n&#x2009;</i>=&#x2009;49), were recruited. Genotyping of selected polymorphisms responsible for viral entry, immune response, and inflammation was performed using MassARRAY system. Out of 37 SNPs, 9 including leucine zipper transcription factor like-1 (<i>LZTFL1</i>) rs10490770 C allele, <i>LZTFL1</i> rs11385942 dupA allele, nicotinamide adenine dinucleotide synthetase-1 (<i>NADSYN1</i>) rs12785878 TT genotype, plexin A-4 (<i>PLXNA4</i>) rs1424597 AA genotype, <i>LZTFL1</i> rs17713054 A allele, interleukin-10 (<i>IL10</i>) rs1800896 TC genotype and C allele, angiotensin converting enzyme-2 (<i>ACE2</i>) rs2285666 T allele, and plasmanylethanolamine desaturase-1 (<i>PEDS1</i>) rs6020298 GG genotype and G allele were significantly associated with an increased risk of developing Long COVID, whereas interleukin-10 receptor subunit beta (<i>IL10RB</i>) rs8178562 GG genotype was significantly associated with a reduced risk of Long COVID. Kaplan-Meier curve displayed that the above gene polymorphisms were significantly associated with cumulative rate of Long COVID occurrence. Polymorphisms in <i>LZTFL1</i> rs10490770, <i>LZTFL1</i> rs11385942, <i>LZTFL1</i> rs17713054, <i>NADSYN1</i> rs12785878, <i>PLXNA4</i> rs1424597, <i>IL10</i> rs1800896, <i>ACE2</i> rs2285666, <i>PEDS1</i> rs6020298, and <i>IL10RB</i> rs8178562 appear to be genetic factors involved in development of Long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Udomsinprasert</LastName><ForeName>Wanvisa</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-1132-7442</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nontawong</LastName><ForeName>Nuttakant</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Prachatipat Hospital, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saengsiwaritt</LastName><ForeName>Wacharapol</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panthan</LastName><ForeName>Bhakbhoom</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiaranai</LastName><ForeName>Poramate</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thongchompoo</LastName><ForeName>Nartthawee</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santon</LastName><ForeName>Siwalee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runcharoen</LastName><ForeName>Chakkaphan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sensorn</LastName><ForeName>Insee</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jittikoon</LastName><ForeName>Jiraphun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaikledkaew</LastName><ForeName>Usa</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chantratita</LastName><ForeName>Wasun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Medical Genomics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 severity</Keyword><Keyword MajorTopicYN="N">Genetic polymorphism</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37497655</ArticleId><ArticleId IdType="pmc">PMC10392286</ArticleId><ArticleId IdType="doi">10.1080/22221751.2023.2239952</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo G, Ye L, Pan K, et al. . New insights of emerging SARS-CoV-2: epidemiology, etiology, clinical features, clinical treatment, and prevention. Front Cell Dev Biol. 2020;8:410. doi:10.3389/fcell.2020.00410</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00410</ArticleId><ArticleId IdType="pmc">PMC7256189</ArticleId><ArticleId IdType="pubmed">32574318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Yang R.. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses. 2020;14:474&#x2013;475. doi:10.1111/irv.12743</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12743</ArticleId><ArticleId IdType="pmc">PMC7228388</ArticleId><ArticleId IdType="pubmed">32246886</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshoabi SA, Alhazmi FH, Abdulaal OM, et al. . Frequent clinical and radiological manifestations of the novel SARS-CoV-2: A review article. J Family Med Prim Care. 2021;10:122&#x2013;126. doi:10.4103/jfmpc.jfmpc_1985_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1985_20</ArticleId><ArticleId IdType="pmc">PMC8132777</ArticleId><ArticleId IdType="pubmed">34017713</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzrodt CL, Maknojia I, McCarthy RDP, et al. . A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J. 2020;287:3633&#x2013;3650. doi:10.1111/febs.15375</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15375</ArticleId><ArticleId IdType="pmc">PMC7283703</ArticleId><ArticleId IdType="pubmed">32446285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;1607. doi:10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi:10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi:10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ghaida J, Foster A, Klein S, et al. . The world-wide adaptations of diabetic management in the face of COVID-19 and socioeconomic disparities: a scoping review. Cureus. 2022;14:e31911. doi:10.7759/cureus.31911</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.31911</ArticleId><ArticleId IdType="pmc">PMC9792358</ArticleId><ArticleId IdType="pubmed">36579222</ArticleId></ArticleIdList></Reference><Reference><Citation>Patar&#x10d;i&#x107; I, Gelemanovi&#x107; A, Kirin M, et al. . The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis. Sci Rep. 2015;5:16119. doi:10.1038/srep16119</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16119</ArticleId><ArticleId IdType="pmc">PMC4630784</ArticleId><ArticleId IdType="pubmed">26524966</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney AD, Dowdle JA, Bozzacco L, et al. . Human genetic determinants of viral diseases. Annu Rev Genet. 2017;51:241&#x2013;263. doi:10.1146/annurev-genet-120116-023425</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-120116-023425</ArticleId><ArticleId IdType="pmc">PMC6038703</ArticleId><ArticleId IdType="pubmed">28853921</ArticleId></ArticleIdList></Reference><Reference><Citation>Debnath M, Banerjee M, Berk M.. Genetic gateways to COVID-19 infection: implications for risk, severity, and outcomes. FASEB J. 2020;34:8787&#x2013;8795. doi:10.1096/fj.202001115R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001115R</ArticleId><ArticleId IdType="pmc">PMC7300732</ArticleId><ArticleId IdType="pubmed">32525600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Lopez O, Daimiel L, Ramirez de Molina A, et al. . Exploring host genetic polymorphisms involved in SARS-CoV infection outcomes: implications for personalized medicine in COVID-19. Int J Genomics. 2020;2020:6901217. doi:10.1155/2020/6901217</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6901217</ArticleId><ArticleId IdType="pmc">PMC7582067</ArticleId><ArticleId IdType="pubmed">33110916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T, Pigazzini S, Degenhardt F, et al. . Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021;131:e152386. doi:10.1172/JCI152386</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152386</ArticleId><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 GWAS Group, Ellinghaus D, Degenhardt F, et al. . Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med. 2020;383:1522&#x2013;1534. doi:10.1056/NEJMoa2020283</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al. . Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: a systematic review with meta-analysis. Rev Med Virol. 2022;32:e2323. doi:10.1002/rmv.2323</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2323</ArticleId><ArticleId IdType="pubmed">34997794</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolmusz VK, Bozsik A, Papp J, et al. . Germline genetic variants of viral entry and innate immunity may influence susceptibility to SARS-CoV-2 infection: toward a polygenic risk score for risk stratification. Front Immunol. 2021;12:6534. doi:10.3389/fimmu.2021.653489</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.653489</ArticleId><ArticleId IdType="pmc">PMC7982482</ArticleId><ArticleId IdType="pubmed">33763088</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastassopoulou C, Gkizarioti Z, Patrinos GP, et al. . Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics. 2020;14:40. doi:10.1186/s40246-020-00290-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-020-00290-4</ArticleId><ArticleId IdType="pmc">PMC7578581</ArticleId><ArticleId IdType="pubmed">33092637</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization 2021 . Clinical management of COVID-19: living guidance 2021:1&#x2013;81.</Citation></Reference><Reference><Citation>NICE COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. [cited 2021 Jan 13]; Available from: https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>The Genome Aggregation Database (gnomAD) v2.1. [cited 2022 May 22]; Available from: https://gnomad.broadinstitute.org.</Citation></Reference><Reference><Citation>Valenti L, Griffini S, Lamorte G, et al. . Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19. J Autoimmun. 2021;117:102595. doi:10.1016/j.jaut.2021.102595</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102595</ArticleId><ArticleId IdType="pmc">PMC7796659</ArticleId><ArticleId IdType="pubmed">33453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotur N, Skakic A, Klaassen K, et al. . Association of vitamin D, zinc and selenium related genetic variants with COVID-19 disease severity. Front Nutr. 2021;8:689419. doi:10.3389/fnut.2021.689419</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.689419</ArticleId><ArticleId IdType="pmc">PMC8211741</ArticleId><ArticleId IdType="pubmed">34150833</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbood SJA, Anvari E, Fateh A.. Association between interleukin-10 gene polymorphisms (rs1800871, rs1800872, and rs1800896) and severity of infection in different SARS-CoV-2 variants. Hum Genomics. 2023;17(1):19. doi:10.1186/s40246-023-00468-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-023-00468-6</ArticleId><ArticleId IdType="pmc">PMC9990970</ArticleId><ArticleId IdType="pubmed">36882862</ArticleId></ArticleIdList></Reference><Reference><Citation>Traets MJM, Nijhuis RHT, Morr&#xe9; SA, et al. . Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19. PLoS One. 2022;17(1):e0260897. doi:10.1371/journal.pone.0260897</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260897</ArticleId><ArticleId IdType="pmc">PMC8740962</ArticleId><ArticleId IdType="pubmed">34995294</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;hlendick B, Sch&#xf6;nfelder K, Breuckmann K, et al. . ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharmacogenet Genomics. 2021;31(8):165&#x2013;171. doi:10.1097/FPC.0000000000000436</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FPC.0000000000000436</ArticleId><ArticleId IdType="pmc">PMC8415730</ArticleId><ArticleId IdType="pubmed">34001841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K, Lapajne L, Petrovi&#x10d; D, et al. . The role of ACE, ACE2, and AGTR2 polymorphisms in COVID-19 severity and the presence of COVID-19-related retinopathy. Genes (Basel). 2022;13(7):1111. doi:10.3390/genes13071111</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13071111</ArticleId><ArticleId IdType="pmc">PMC9318051</ArticleId><ArticleId IdType="pubmed">35885894</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalilzadeh F, Sakhaee F, Sotoodehnejadnematalahi F, et al. . Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population. Int J Immunogenet. 2022;49(5):325&#x2013;332. doi:10.1111/iji.12598</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iji.12598</ArticleId><ArticleId IdType="pmc">PMC9539076</ArticleId><ArticleId IdType="pubmed">36029284</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Cai S, Feng H, et al. . Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients. Protein Cell. 2020;11:680&#x2013;687. doi:10.1007/s13238-020-00752-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00752-4</ArticleId><ArticleId IdType="pmc">PMC7363016</ArticleId><ArticleId IdType="pubmed">32671793</ArticleId></ArticleIdList></Reference><Reference><Citation>Borczuk AC, Salvatore SP, Seshan SV, et al. . COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York city. Mod Pathol. 2020;33:2156&#x2013;2168. doi:10.1038/s41379-020-00661-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-00661-1</ArticleId><ArticleId IdType="pmc">PMC7463226</ArticleId><ArticleId IdType="pubmed">32879413</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes DJ, Cross AR, Hua P, et al. . Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet. 2021;53:1606&#x2013;1615. doi:10.1038/s41588-021-00955-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00955-3</ArticleId><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra NG, Alfajaro MM, Gasque V, et al. . Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol. 2021;19:e3001143. doi:10.1371/journal.pbio.3001143</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001143</ArticleId><ArticleId IdType="pmc">PMC8007021</ArticleId><ArticleId IdType="pubmed">33730024</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Macdonald-Dunlop E, Chen J, et al. . Genetic landscape of the ACE2 coronavirus receptor. Circulation. 2022;145:1398&#x2013;1411. doi:10.1161/CIRCULATIONAHA.121.057888</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057888</ArticleId><ArticleId IdType="pmc">PMC9047645</ArticleId><ArticleId IdType="pubmed">35387486</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant WB, Lahore H, McDonnell SL, et al. . Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988. doi:10.3390/nu12040988</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12040988</ArticleId><ArticleId IdType="pmc">PMC7352449</ArticleId><ArticleId IdType="pubmed">32492787</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossein-nezhad A, Spira A, Holick MF.. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8:e58725. doi:10.1371/journal.pone.0058725</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058725</ArticleId><ArticleId IdType="pmc">PMC3604145</ArticleId><ArticleId IdType="pubmed">23527013</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas AT, Calhau C, Antunes G, et al. . Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep. 2021;11:20837. doi:10.1038/s41598-021-99952-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99952-z</ArticleId><ArticleId IdType="pmc">PMC8531279</ArticleId><ArticleId IdType="pubmed">34675344</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaq M, Iglesias MJ, Ibrahim-Kosta M, et al. . An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism. Sci Rep. 2021;11:14015. doi:10.1038/s41598-021-93390-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93390-7</ArticleId><ArticleId IdType="pmc">PMC8263618</ArticleId><ArticleId IdType="pubmed">34234248</ArticleId></ArticleIdList></Reference><Reference><Citation>Fard D, Tamagnone L.. Semaphorins in health and disease. Cytokine Growth Factor Rev. 2021;57:55&#x2013;63. doi:10.1016/j.cytogfr.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.006</ArticleId><ArticleId IdType="pubmed">32900601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, et al. . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620&#x2013;2629. doi:10.1172/JCI137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Karcioglu Batur L, Hekim N.. Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J Med Virol. 2021;93:5853&#x2013;5863. doi:10.1002/jmv.27127</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27127</ArticleId><ArticleId IdType="pmc">PMC8242628</ArticleId><ArticleId IdType="pubmed">34081354</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshandeh B, Sorboni SG, Javanmard AR, et al. . Variants in ACE2; potential influences on virus infection and COVID-19 severity. Infect Genet Evol. 2021;90:104773. doi:10.1016/j.meegid.2021.104773</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104773</ArticleId><ArticleId IdType="pmc">PMC7886638</ArticleId><ArticleId IdType="pubmed">33607284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-G&#xf3;mez LE, Herrera-L&#xf3;pez B, Martinez-Armenta C, et al. . ACE and ACE2 gene variants are associated with severe outcomes of COVID-19 in men. Front Immunol. 2022;13:812940. doi:10.3389/fimmu.2022.812940</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.812940</ArticleId><ArticleId IdType="pmc">PMC8892378</ArticleId><ArticleId IdType="pubmed">35250987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Huang S, Gao R, et al. . Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discov. 2020;6:83. doi:10.1038/s41421-020-00231-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00231-4</ArticleId><ArticleId IdType="pmc">PMC7653987</ArticleId><ArticleId IdType="pubmed">33298875</ArticleId></ArticleIdList></Reference><Reference><Citation>Voloudakis G, Vicari JM, Venkatesh S, et al. . A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility. NPJ Genom Med. 2022;7:52. doi:10.1038/s41525-022-00324-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-022-00324-x</ArticleId><ArticleId IdType="pmc">PMC9441828</ArticleId><ArticleId IdType="pubmed">36064543</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Dong X, Guo S, et al. . Regulation of the human IL-10RB gene expression by Sp8 and Sp9. J Alzheimers Dis. 2022;88:1469&#x2013;1485. doi:10.3233/JAD-220321</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220321</ArticleId><ArticleId IdType="pubmed">35811529</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakas Celik S, Cakmak Genc G, Dursun A.. A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression. Int J Immunogenet. 2021;48:211&#x2013;218. doi:10.1111/iji.12522</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iji.12522</ArticleId><ArticleId IdType="pmc">PMC7753408</ArticleId><ArticleId IdType="pubmed">33246355</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaka&#x15f; &#xc7;elik S, &#xc7;akmak Gen&#xe7; G, et al. . Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: a case study. J Med Virol. 2021;93(10):5947&#x2013;5952. doi:10.1002/jmv.27160</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27160</ArticleId><ArticleId IdType="pmc">PMC8426884</ArticleId><ArticleId IdType="pubmed">34170561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>